图解浙江震元中报：第二季度单季净利润同比下降16.05%

Core Viewpoint - Zhejiang Zhenyuan's 2025 mid-year report indicates a significant decline in main revenue while showing an increase in net profit attributable to shareholders, highlighting mixed financial performance amid challenging market conditions [1]. Financial Performance Summary - Main revenue for the first half of 2025 reached 1.283 billion yuan, a year-on-year decrease of 34.49% [1]. - Net profit attributable to shareholders was 56.2637 million yuan, reflecting a year-on-year increase of 29.27% [1]. - Non-recurring net profit stood at 30.1173 million yuan, down 20.32% year-on-year [1]. - In Q2 2025, the company reported a single-quarter main revenue of 532 million yuan, a decline of 41.85% year-on-year [1]. - Single-quarter net profit attributable to shareholders was 20.3811 million yuan, a decrease of 16.05% year-on-year [1]. - Single-quarter non-recurring net profit was 17.7461 million yuan, down 7.88% year-on-year [1]. Financial Ratios and Metrics - The company's debt ratio was reported at 31.92% [1]. - Investment income amounted to 30.9642 million yuan, with financial expenses recorded at -1.8204 million yuan [1]. - Gross profit margin was 25.42%, showing an increase of 32.10% year-on-year [7]. - Return on assets was 2.82%, up 28.18% year-on-year [7]. - Earnings per share were 0.17 yuan, reflecting a year-on-year increase of 30.76% [7]. - Operating cash flow per share was 0.02 yuan, down 95.35% year-on-year [7]. Shareholder Information - The largest shareholder is Shaoxing Zhenyuan Health Industry Group Co., Ltd., holding 31.23 million shares, which is 11.07% of total shares [11]. - Other notable shareholders include individuals and institutions with varying percentages, indicating a diverse shareholder base [11][12].